Tuomas Rannio

Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data

Elena Nikiphorou, Hannu Kautiainen, Pekka Hannonen et al. · Expert Opinion on Biological Therapy · 2015 · 113 citations

Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study.

Kirsi Paalanen, Katja Rannio, Tuomas Rannio et al. · PubMed · 2019 · 46 citations

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin et al. · Annals of the Rheumatic Diseases · 2023 · 44 citations · Full text

Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice

Kalle Aaltonen, Suvi Ylikylä, Jaana Joensuu et al. · Lara D. Veeken · 2016 · 40 citations · Full text

Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics.

Tuulikki Sokka, Glenn Haugeberg, Juha Asikainen et al. · PubMed · 2013 · 36 citations